Vincenzo Tufaro

Vincenzo Tufaro

Auto-generated profile, based on publicly available information

Vincenzo Tufaro

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Atherosclerosis
Verified
Journal Article
Closed access
VTVincenzo Tufaro
Vincenzo Tufaro
HSHannah Safi
Hannah Safi
RTRyo Torii
Ryo Torii
BKBon-Kwon Koo
Bon-Kwon Koo
PKPieter Kitslaar
Pieter Kitslaar
Christos BourantasChristos Bourantas
Christos Bourantas

8 April 2022 in Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
VTVincenzo Tufaro
Vincenzo Tufaro
PSPatrick Washington Serruys
Patrick Washington Serruys
LRLorenz Räber
Lorenz Räber
MBMartin Bennett
Martin Bennett
RTRyo Torii
Ryo Torii
Christos BourantasChristos Bourantas
Christos Bourantas
Intravascular imaging has been often used over the recent years to examine the efficacy of emerging therapies targeting plaque evolution. Serial intravascular ultrasound, optical coherence tomography, or near-infrared spectroscopy-intravascular ultrasound studies have allowed us to evaluate the effects of different therapies on plaque burden and morphology, providing unique mechanistic insights about the mode of action of these treatments. Plaque burden reduction, a decrease in necrotic core component or macrophage accumulation—which has been associated with inflammation—and an increase in fibrous cap thickness over fibroatheromas have been used as surrogate endpoints to assess the value of several drugs in inhibiting plaque evolution and improving clinical outcomes. However, some reports have demonstrated weak associations between the effects of novel treatments on coronary atheroma and composition and their prognostic implications. This review examines the value of invasive imaging in assessing pharmacotherapies targeting atherosclerosis. It summarizes the findings of serial intravascular imaging studies assessing the effects of different drugs on atheroma burden and morphology and compares them with the results of large-scale trials evaluating their impact on clinical outcome. Furthermore, it highlights the limited efficacy of established intravascular imaging surrogate endpoints in predicting the prognostic value of these pharmacotherapies and introduces alternative imaging endpoints based on multimodality/hybrid intravascular imaging that may enable more accurate assessment of the athero-protective and prognostic effects of emerging therapies.

19 December 2024 in Atherosclerosis
Verified
Journal Article
Closed access
VTVincenzo Tufaro
Vincenzo Tufaro
RTRyo Torii
Ryo Torii
JAJean-Paul Aben
Jean-Paul Aben
RPRamya Parasa
Ramya Parasa
BKBon-Kwon Koo
Bon-Kwon Koo
Christos BourantasChristos Bourantas
Christos Bourantas

14 October 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
FBFrancesco Bandera
Francesco Bandera
GGGreta Generati
Greta Generati
MPMarta Pellegrino
Marta Pellegrino
VTVincenzo Tufaro
Vincenzo Tufaro
FSFrancesco Secchi
Francesco Secchi
MGMarco Guazzi
Marco Guazzi

2 September 2019 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
VTVincenzo Tufaro
Vincenzo Tufaro
Gianfranco ButeraGianfranco Butera
Gianfranco Butera
A new approach was used in the percutaneous treatment of two patients with severe recoarctation involving the origin of the left subclavian artery. A tiny handmade fenestration was created in a NuMED-covered Cheatham-platinum stent before its implantation to avoid left subclavian artery occlusion. The stent placement was performed using a two-guidewire technique in which the different stiffness helped a proper positioning of the stent. After the stent deployment, the fenestration was enlarged performing a balloon angioplasty to improve flow in left subclavian artery.

1 July 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
EEEmrah Erdogan
Emrah Erdogan
ZLZheng Li
Zheng Li
YZYong-Xiang Zhu
Yong-Xiang Zhu
VTVincenzo Tufaro
Vincenzo Tufaro
SFSi-Li Feng
Si-Li Feng
YZYao-Jun Zhang
Yao-Jun Zhang